Title: Mantle Cell Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20160410
Title: Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia.
Journal: The New England journal of medicine 20160128
Title: Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor.
Journal: Journal of hematology & oncology 20160101
Title: Wu J, et al. Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor. J Hematol Oncol. 2016 Mar 9;9:21
Title: Herman SE, et al. The Bruton's tyrosine kinase (BTK) inhibitor acalabrutinib demonstrates potent on-target effects and efficacy in two mouse models of chronic lymphocytic leukemia. Clin Cancer Res. 2016 Nov 30